NM_000089.4:c.595-125A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000089.4(COL1A2):​c.595-125A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.237 in 795,514 control chromosomes in the GnomAD database, including 24,009 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3664 hom., cov: 32)
Exomes 𝑓: 0.25 ( 20345 hom. )

Consequence

COL1A2
NM_000089.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.470

Publications

10 publications found
Variant links:
Genes affected
COL1A2 (HGNC:2198): (collagen type I alpha 2 chain) This gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
COL1A2 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome, arthrochalasia type, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Illumina, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • osteogenesis imperfecta
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • osteogenesis imperfecta type 1
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • osteogenesis imperfecta type 2
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
  • osteogenesis imperfecta type 3
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • osteogenesis imperfecta type 4
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Ehlers-Danlos syndrome, arthrochalasia type
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • Ehlers-Danlos syndrome, cardiac valvular type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, PanelApp Australia, Orphanet, G2P
  • combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen, Ambry Genetics
  • Ehlers-Danlos/osteogenesis imperfecta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • high bone mass osteogenesis imperfecta
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 7-94407722-A-G is Benign according to our data. Variant chr7-94407722-A-G is described in ClinVar as Benign. ClinVar VariationId is 1227903.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.254 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL1A2NM_000089.4 linkc.595-125A>G intron_variant Intron 12 of 51 ENST00000297268.11 NP_000080.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL1A2ENST00000297268.11 linkc.595-125A>G intron_variant Intron 12 of 51 1 NM_000089.4 ENSP00000297268.6

Frequencies

GnomAD3 genomes
AF:
0.197
AC:
29879
AN:
152050
Hom.:
3667
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0578
Gnomad AMI
AF:
0.234
Gnomad AMR
AF:
0.190
Gnomad ASJ
AF:
0.224
Gnomad EAS
AF:
0.266
Gnomad SAS
AF:
0.260
Gnomad FIN
AF:
0.333
Gnomad MID
AF:
0.215
Gnomad NFE
AF:
0.250
Gnomad OTH
AF:
0.186
GnomAD4 exome
AF:
0.246
AC:
158576
AN:
643346
Hom.:
20345
AF XY:
0.248
AC XY:
83756
AN XY:
338124
show subpopulations
African (AFR)
AF:
0.0536
AC:
839
AN:
15654
American (AMR)
AF:
0.166
AC:
4315
AN:
25992
Ashkenazi Jewish (ASJ)
AF:
0.226
AC:
3953
AN:
17478
East Asian (EAS)
AF:
0.263
AC:
8137
AN:
30886
South Asian (SAS)
AF:
0.262
AC:
14436
AN:
55106
European-Finnish (FIN)
AF:
0.323
AC:
14310
AN:
44258
Middle Eastern (MID)
AF:
0.185
AC:
424
AN:
2298
European-Non Finnish (NFE)
AF:
0.250
AC:
104935
AN:
419986
Other (OTH)
AF:
0.228
AC:
7227
AN:
31688
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
5779
11558
17338
23117
28896
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1882
3764
5646
7528
9410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.196
AC:
29860
AN:
152168
Hom.:
3664
Cov.:
32
AF XY:
0.201
AC XY:
14917
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.0577
AC:
2399
AN:
41572
American (AMR)
AF:
0.190
AC:
2897
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.224
AC:
776
AN:
3472
East Asian (EAS)
AF:
0.265
AC:
1373
AN:
5176
South Asian (SAS)
AF:
0.259
AC:
1249
AN:
4824
European-Finnish (FIN)
AF:
0.333
AC:
3511
AN:
10546
Middle Eastern (MID)
AF:
0.211
AC:
62
AN:
294
European-Non Finnish (NFE)
AF:
0.250
AC:
16990
AN:
67972
Other (OTH)
AF:
0.184
AC:
390
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1209
2418
3627
4836
6045
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
326
652
978
1304
1630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.155
Hom.:
1167
Bravo
AF:
0.178
Asia WGS
AF:
0.226
AC:
783
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
8.4
DANN
Benign
0.85
PhyloP100
-0.47
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs42517; hg19: chr7-94037034; API